Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Restructuring Costs (2022)

Historic Restructuring Costs for Cardio Diagnostics Holdings (CDIOW) over the last 1 years, with Q2 2022 value amounting to $55034.0.

  • Cardio Diagnostics Holdings' Restructuring Costs changed N/A to $55034.0 in Q2 2022 from the same period last year, while for Mar 2023 it was $55034.0, marking a year-over-year change of. This contributed to the annual value of $112534.0 for FY2022, which is N/A changed from last year.
  • Cardio Diagnostics Holdings' Restructuring Costs amounted to $55034.0 in Q2 2022.
  • Cardio Diagnostics Holdings' Restructuring Costs' 5-year high stood at $57500.0 during Q1 2022, with a 5-year trough of $55034.0 in Q2 2022.